Back to search

Aristotle University Of Thessaloniki (AUTH)

Η υποκλασματική ακτινοθεραπεία με διαμορφούμενης έντασης δέσμες στον καρκίνο του προστάτη

Abstract

dc:description

Introduction: prostate cancer is a disease highly sensitive to radiation therapy (RT) dose per fraction (fr) modifications, specifically to daily dose escalation, a method called hypofractionation. Hypofractionation can electively cause an increase in the total dose distributed to the prostate while a milder increase is observed in the surrounding normal tissues. This in turn can lead shorter treatment duration and potentially better disease control with less toxicity. In this trial we present the results of a comparison in the toxicity profile between a conventionally fractionated RT scheme of 2 Gy/fr to a total dose of 74 Gy and a hypofractionated scheme of 72 Gy with 2.25 Gy/fr. Materials and methods: Patients included in the study had localized prostate cancer (cT1c-T3bN0M0) and were randomly assigned to hypofractionated (72 Gy in 32 fractions, arm1) or conventionally fractionated (74 Gy in 37 fractions, arm2) radiation therapy treatment with Volumetric Arc Therapy technique. The treatment was delivered only to the prostate with or without the seminal vesicles according to physician’s discretion and hormone therapy was optional according to the disease stage and comorbidities. The study’s endpoint was the impact of RT treatment on acute and late adverse events from gastrointestinal (GI) and genitourinary (GU) system which was evaluated by the Radiation Therapy Oncology Group toxicity scale and by quality of life reporting questionnaires (Expanded Prostate index Composite, EPIC)Results:139 patients were recruited in the study, from which 72 received HRT and 67 CRT. At 4 years after the start of the trial, 23 patients (31,9%) from arm 1 developed grade≥ 2 acute genitourinary toxicity and 21 (31,3%) from arm 2 (p=0,79). The corresponding values from gastrointestinal were 15 (20,8%) and 12 (17,9%) (p=0,6). None of the population’s baseline characteristics was associated with acute adverse events from either GU or GI. For late toxicity from GU, 8 patients (11,1%) developed grade≥ 2 symptoms in arm 1 and 7 (10,4%) in arm 2 (p=0,92). late GI toxicity grade≥ 2 was observed in 8 (11,1%) patients in arm 1 and 8 (11,9%) in arm 2 (p=0,88). In multivariate analysis, hormone therapy was significantly associated with late GI events (p=0.016), while acute toxicity from both GU and GI was a prognostic factor of late adverse reaction (p=0.006 and 0.001 respectively). Conclusion: No difference in the acute or late toxicity profile could be identified between hypofractionation and conventional fractionation. Our schedule of 2,25Gy/fr seems safe and tolerable by the patients with acceptable rates of acute and late toxicity.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Alexidis, Petros
  • Αλεξίδης, Πέτρος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47787

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Alexidis, Petros; Αλεξίδης, Πέτρος. Η υποκλασματική ακτινοθεραπεία με διαμορφούμενης έντασης δέσμες στον καρκίνο του προστάτη. Aristotle University Of Thessaloniki (AUTH), 2020. http://hdl.handle.net/10442/hedi/47787